KatinaRobisonMD

Obstetrics & Gynecology • Providence, RI

Gynecologic Oncology

Associate Professor, Obstetrics and Gynecology, Brown University Program in Medicine

Join to view full profile

Dr. Robison is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Robison's full profile

Already have an account?

Office
101 Dudley St
Providence, RI 02905
Phone+1 401-274-1100

Education & Training

Women and Infants Hospital of Rhode Island/Brown UniversityFellowship, Gynecologic Oncology, 2006 - 2009
Women and Infants Hospital of Rhode Island/Brown UniversityResidency, Obstetrics and Gynecology, 2002 - 2006
University of Pittsburgh School of MedicineClass of 2002

Certifications & Licensure

MA State Medical License 2009 - 2026
RI State Medical License 2003 - 2024
CT State Medical License 2009 - 2023
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Cancer of the Uterus and Treatment of Stress Urinary Incontinence Start of enrollment: 2016 Jan 01
Unknown status
Vaginal Dilator Therapy Among Women With Gynecologic and Breast Cancers Experiencing Dyspareunia Start of enrollment: 2022 Aug 03
Withdrawn
Not Applicable
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

181 citations
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT...
Kathleen N. Moore, Michael A. Bookman, Jalid Sehouli, Austin Miller, Charles K. Anderson
Journal of Clinical Oncology. 2021-04-23
93 citations
Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
Terri Febbraro, Katina Robison, Jennifer Scalia Wilbur, Jessica Laprise, Amy Bregar
Gynecologic Oncology. 2012-03-01
10 citations
Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
Israel Zighelboim, Shamshad Ali, Heather A. Lankes, Floor J. Backes, Kathleen N. Moore
Gynecologic Oncology. 2015-09-01

Press Mentions

Can Progestin Birth Control Actually Increase Your Breast Cancer Risk?April 11th, 2023
Can Progestin Birth Control Actually Increase Your Breast Cancer Risk?April 10th, 2023
Having Meaningful Conversations After a Cancer DiagnosisOctober 31st, 2017
Join now to see all